Amphastar Pharmaceuticals, Inc. (AMPH)
USD 23.75
(-5.0%)
USD 23.75
(-5.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 105.83 Million USD | 2.17% |
| 2022 | 103.58 Million USD | 11.61% |
| 2021 | 92.8 Million USD | -4.16% |
| 2020 | 96.83 Million USD | -12.37% |
| 2019 | 110.5 Million USD | 59.4% |
| 2018 | 69.32 Million USD | 8.98% |
| 2017 | 63.6 Million USD | -20.24% |
| 2016 | 79.75 Million USD | 12.86% |
| 2015 | 70.66 Million USD | -14.17% |
| 2014 | 82.33 Million USD | 17.76% |
| 2013 | 69.91 Million USD | 36.08% |
| 2012 | 51.37 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 115.49 Million USD | 9.13% |
| 2024 Q2 | 122.41 Million USD | 5.99% |
| 2023 Q2 | 104.61 Million USD | 0.94% |
| 2023 Q4 | 105.83 Million USD | -3.77% |
| 2023 FY | 105.83 Million USD | 2.17% |
| 2023 Q1 | 103.64 Million USD | 0.06% |
| 2023 Q3 | 109.97 Million USD | 5.12% |
| 2022 Q4 | 103.58 Million USD | 0.32% |
| 2022 Q3 | 103.25 Million USD | 4.57% |
| 2022 FY | 103.58 Million USD | 11.61% |
| 2022 Q1 | 95.14 Million USD | 2.52% |
| 2022 Q2 | 98.73 Million USD | 3.77% |
| 2021 Q3 | 100.24 Million USD | 2.36% |
| 2021 Q2 | 97.93 Million USD | 0.85% |
| 2021 Q1 | 97.11 Million USD | 0.29% |
| 2021 FY | 92.8 Million USD | -4.16% |
| 2021 Q4 | 92.8 Million USD | -7.42% |
| 2020 Q2 | 104.72 Million USD | -2.94% |
| 2020 Q3 | 108.87 Million USD | 3.96% |
| 2020 Q4 | 96.83 Million USD | -11.06% |
| 2020 FY | 96.83 Million USD | -12.37% |
| 2020 Q1 | 107.9 Million USD | -2.35% |
| 2019 Q1 | 78.58 Million USD | 13.36% |
| 2019 FY | 110.5 Million USD | 59.4% |
| 2019 Q4 | 110.5 Million USD | 0.59% |
| 2019 Q3 | 109.85 Million USD | 10.7% |
| 2019 Q2 | 99.23 Million USD | 26.28% |
| 2018 Q1 | 62.78 Million USD | -1.3% |
| 2018 FY | 69.32 Million USD | 8.98% |
| 2018 Q4 | 69.32 Million USD | 5.97% |
| 2018 Q3 | 65.41 Million USD | 6.06% |
| 2018 Q2 | 61.67 Million USD | -1.76% |
| 2017 Q4 | 63.6 Million USD | -8.66% |
| 2017 FY | 63.6 Million USD | -20.24% |
| 2017 Q1 | 78.13 Million USD | -2.03% |
| 2017 Q2 | 74.45 Million USD | -4.71% |
| 2017 Q3 | 69.64 Million USD | -6.47% |
| 2016 Q1 | 82.24 Million USD | 16.38% |
| 2016 FY | 79.75 Million USD | 12.86% |
| 2016 Q4 | 79.75 Million USD | -12.02% |
| 2016 Q3 | 90.65 Million USD | 2.63% |
| 2016 Q2 | 88.32 Million USD | 7.4% |
| 2015 Q3 | 72.42 Million USD | -9.67% |
| 2015 Q2 | 80.17 Million USD | -5.55% |
| 2015 Q1 | 84.88 Million USD | 3.1% |
| 2015 FY | 70.66 Million USD | -14.17% |
| 2015 Q4 | 70.66 Million USD | -2.43% |
| 2014 Q4 | 82.33 Million USD | -6.5% |
| 2014 Q3 | 88.05 Million USD | -16.95% |
| 2014 Q2 | 106.01 Million USD | 34.12% |
| 2014 Q1 | 79.04 Million USD | 13.06% |
| 2014 FY | 82.33 Million USD | 17.76% |
| 2013 Q3 | 60.07 Million USD | 0.0% |
| 2013 Q4 | 69.91 Million USD | 16.39% |
| 2013 Q1 | - USD | -100.0% |
| 2013 FY | 69.91 Million USD | 36.08% |
| 2012 Q4 | 51.37 Million USD | 0.0% |
| 2012 FY | 51.37 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Journey Medical Corporation | 10.2 Million USD | -936.968% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 4.823% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -1463.495% |
| Pacira BioSciences, Inc. | 104.35 Million USD | -1.418% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -1745.467% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -1745.467% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| Safety Shot Inc | 1.86 Million USD | -5560.587% |
| Alpha Teknova, Inc. | 11.59 Million USD | -812.826% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | -227.332% |
| Bright Green Corporation | - USD | -Infinity% |
| Dynavax Technologies Corporation | 53.29 Million USD | -98.598% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | -61.274% |
| Cosmos Health Inc. | 4.78 Million USD | -2109.894% |
| PainReform Ltd. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -12969.723% |
| Embecta Corp. | 152.1 Million USD | 30.419% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | -808.672% |
| Procaps Group, S.A. | 96.83 Million USD | -9.294% |
| Theratechnologies Inc. | 6.06 Million USD | -1644.692% |
| Harrow Health, Inc. | 10.86 Million USD | -873.893% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -3792.35% |
| Biofrontera Inc. | 10.9 Million USD | -870.233% |
| DURECT Corporation | 2.21 Million USD | -4669.401% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | -36.721% |
| Cronos Group Inc. | 30.33 Million USD | -248.835% |
| OptiNose, Inc. | 8.05 Million USD | -1214.369% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -10583299900.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -1757.034% |
| Organogenesis Holdings Inc. | 28.25 Million USD | -274.59% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -3853.253% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -2196.044% |
| Radius Health, Inc. | 278.64 Million USD | 62.018% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -3065.557% |
| ProPhase Labs, Inc. | 3.84 Million USD | -2655.35% |
| Phibro Animal Health Corporation | 265.91 Million USD | 60.2% |
| Procaps Group S.A. | 96.83 Million USD | -9.294% |
| Alvotech | 74.43 Million USD | -42.186% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 96.95% |
| Rockwell Medical, Inc. | 5.87 Million USD | -1702.64% |
| Aytu BioPharma, Inc. | 12.63 Million USD | -737.75% |
| SIGA Technologies, Inc. | 64.21 Million USD | -64.802% |
| Tilray Brands, Inc. | 252.08 Million USD | 58.017% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | -164.721% |
| Shineco, Inc. | 1.58 Million USD | -6562.344% |
| PetIQ, Inc. | 159.3 Million USD | 33.567% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 69372.408% |
| Incannex Healthcare Limited | -10.01 Million USD | 1156.745% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | -176.326% |
| Alimera Sciences, Inc. | 1.87 Million USD | -5532.411% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | -180.828% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -6471.882% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | -2260.763% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -41508.873% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | -919.586% |
| Hempacco Co., Inc. | 2.54 Million USD | -4062.347% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | -42.186% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | -121.436% |
| Lantheus Holdings, Inc. | 64.02 Million USD | -65.289% |
| Currenc Group, Inc. | 732.91 Thousand USD | -14340.089% |
| Kamada Ltd. | 87.74 Million USD | -20.612% |
| Indivior PLC | 141.79 Million USD | 25.364% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -21864.345% |
| Flora Growth Corp. | 8.5 Million USD | -1143.923% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -41508.873% |
| Evolus, Inc. | 10.99 Million USD | -862.293% |
| HUTCHMED (China) Limited | 50.25 Million USD | -110.579% |
| Akanda Corp. | 1.28 Million USD | -8123.91% |